http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201071043-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-54
filingDate 2009-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201071043-A1
titleOfInvention NEW DERIVATIVES 1-BENZYL-3-HYDROXYMETHYLINDASOL AND THEIR APPLICATION IN THE TREATMENT OF DISEASES CAUSED BY EXPRESSION OF MCP-1 AND CX3CR1
abstract The present invention relates to new derivatives of 1-benzyl-3-hydroxymethylindazole according to formula (I) described in the claims, and a pharmaceutical composition containing them together with a pharmaceutically acceptable excipient. In addition, the present invention relates to the use of new derivatives of 1-benzyl-3-hydroxymethylindazole to obtain a pharmaceutical composition that is active in the treatment of diseases caused by the expression of MCP-1 and CX3CR1, and their use in a method of treating or preventing diseases caused by the expression of MCP -1 and CX3CR1.
priorityDate 2008-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403981
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13051
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100172740
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6347
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA6QNL7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1524
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20296
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID563208
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100124525
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35411
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397422
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID171056
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281043
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100034136
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420140913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10657568
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Z0D9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009130
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24770
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49238

Total number of triples: 54.